8 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
• HIV: 2/3 pulmonary ... characteristic features Clinical ... Tuberculosis Diagnosis ... Active TB: • ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
• HIV: 2/3 pulmonary ... characteristic features Clinical ... Tuberculosis Diagnosis ... Active TB: • ... #Diagnosis #Management
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
extrapulmonary cases Clinical ... signs/symptoms of active ... pulmonary TB PE ... RIPE therapy for 2 ... #Diagnosis #Management
On the left some diseases with a nodular pattern.
1. Hypersensitivity pneumonitis: ill defined centrilobular nodules.
2. Miliary
the left some diseases ... centrilobular nodules. 2. ... a patient with active ... #Clinical #Diagnosis ... #Radiology #Pulmonary
Blastomycosis (Blastomyces): Gilchrist’s disease, Chicago disease - Summary Sheet
 • Morphology
 • Geography, Reservoir and Mode
inoculation • Clinical ... presentation of TB ... • Management ... - Pulmonary disease ... Amphotericin B for 1-2
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Inoculum 2. ... Lung Abscess - Clinical ... westermani • Other: TB ... Lung #Abscess #pulmonary
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
worsening of that disease ... the first 1 to 2 ... • Persistently active ... starting ART < 2 ... #Management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
• Cytopenia: 2% ... salivary ducts Clinical ... : • 10%-15% Pulmonary ... muscarinic agonists • Active ... #Management